Filter
358
Text search:
Food
and
Drug
Administration
(FDA)
Featured
Recommendations
38
New Publications
80
Language
Document type
No document type
192
Guidelines
81
Studies & Reports
47
Manuals
13
Fact sheets
9
Strategic & Response Plan
8
Training Material
2
Situation Updates
2
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
Ghana
14
India
14
Myanmar / Burma
11
Philippines
9
Russia
7
Global
7
Nigeria
6
USA
6
South Africa
6
Latin America and the Carribbean
6
Uganda
5
Western and Central Europe
5
Congo, Democratic Republic of
4
South Sudan
4
Ethiopia
3
Nepal
3
Germany
3
Kenya
3
Thailand
3
Indonesia
3
Syria
2
Tanzania
2
Rwanda
2
Bangladesh
2
Sudan
2
Namibia
2
Peru
2
Brazil
2
Colombia
2
Angola
2
West and Central Africa
2
Middle East and North Africa
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Paraguay
2
Africa
2
Sierra Leone
1
Liberia
1
Senegal
1
Guinea-Bissau
1
Zimbabwe
1
Haiti
1
Iraq
1
Jordan
1
Cambodia
1
Singapore
1
Malawi
1
Mozambique
1
Argentina
1
Botswana
1
Yemen
1
Asia
1
Venezuela
1
Eastern Europe
1
Authors & Publishers
Publication Years
Category
Countries
102
Clinical Guidelines
60
Pharmacy & Technologies
16
Women & Child Health
10
Public Health
9
Key Resources
3
Capacity Building
2
Toolboxes
COVID-19
51
Mental Health
37
HIV
35
TB
34
AMR
21
Pharmacy
18
Ebola & Marburg
12
Specific Hazards
9
NTDs
9
NCDs
8
Rapid Response
7
Malaria
7
Planetary Health
5
Refugee
4
Cholera
3
Zika
3
Conflict
2
Global Health Education
2
Disability
1
Caregiver
1
The National Malaria Elimination Strategic Plan (NMESP) 2024–2028 of Ghana outlines the country’s roadmap to shift from malaria control to elimination. Despite major progress—like reducing malaria deaths from nearly 2,800 in 2012 to 151 in 2022—malaria remains a major public health challenge
...
Standard Treatment Guideline
Временное руководство23 декабря 2020 г.
Ce document fournit des orientations provisoires sur la qualité, les caractéristiques de performance et les normes connexes des équipements de protection individuelle (EPI) à utiliser dans le contexte de COVID-19. Il s'agit notamment des dispositifs médicaux prioritaires de l'OMS, à savoir : l
...
28 January 2021. The purpose of this document is to provide interim guidance on laboratory biosafety related to the testing of clinical specimens of patients.
Ciudad de México, México - 26 al 28 de mayo del 2014
Anxiety disorders
Chapter F.2